3D Systems’ Extrusion Technology to Produce Patient-specific PEEK Implants Supports Ground-breaking Cranial Surgeries at Leading European Hospitals
17 Octubre 2023 - 7:30AM
Today, 3D Systems (NYSE:DDD) announced a patient-specific
3D-printed cranial implant produced using its point-of-care
technologies was successfully used in a cranioplasty at the
University Hospital Basel (Switzerland). Under the leadership of
Prof. Florian Thieringer, head of the Medical Additive
Manufacturing Research Group (Swiss MAM) at the University Hospital
Basel's Department of Biomedical Engineering (UNIBAS DBE), and the
Department of Oral and Maxillofacial Surgery (OMFS), in
collaboration with Prof. Raphael Guzman and the Department
of Neurosurgery, the team employed 3D Systems’ technologies to
produce the first cranial implant at the point of care that
complies with the current Medical Devices Regulations (MDR). 3D
Systems’ extrusion printing technology is unique as its
architecture and design are easy to use to produce durable,
biocompatible implants using Polyetheretherketone (PEEK) material.
Additionally, the technology enables the production of
patient-specific geometries at the hospital itself providing
tremendous benefits to both surgeons and patients. The implant
created by the team at University Hospital Basel was used to
successfully replace a section of disintegrating skull in a
46-year-old male who was experiencing complications from a stroke
in 2019.
When the patient first entered Prof. Guzman’s care, he was
experiencing visual disturbances, severe headaches, and dizziness,
and his forehead was sinking due to a disintegrating skullcap. The
University Hospital Basel team under the guidance of Dr. Neha
Sharma, Ph.D. first took a computed tomography (CT) scan of the
patient’s skull and imported that into software to create a model
of the implant customized to his unique anatomy. The implant was
then produced in the Hospital’s 3D printing lab using
VESTAKEEP® i4 3DF PEEK by Evonik on 3D Systems’ EXT 220
MED extrusion platform. PEEK is a very desirable material for such
applications due to its mechanical properties (i.e., lightweight,
resistant to thermal and ionizing radiation, and similar to human
bone). 3D Systems’ printing technology has been uniquely
engineered to enable healthcare applications within sterile
environments.
“The successful implantation at the University Hospital of Basel
is a pivotal moment for medical 3D printing, demonstrating its
potential to revolutionize patient care,” said Prof. Thieringer.
“Our collaboration with hospitals across Europe, along with the
invaluable expertise provided by POC APP AG around QMS and
regulatory guidelines, showcases the power of advanced technology
and collaboration in improving healthcare outcomes.”
3D Systems’ point-of-care solution was also successfully used by
a team at Salzburg University Hospital, Department of
Oromaxillofacial Surgery, to produce a patient-specific cranial
implant for a 55-year-old male, Mr. Rainer Trummer, who suffered
from craniosynostosis (i.e., one of the cranial bones ossified too
early during childhood, resulting in a deformation of the skull).
These technologies were brought together by the hospital’s in-house
clinicians to successfully address the patient’s needs, providing a
customized solution that best positioned the team for success. The
hospital used Oqton’s D2P® software to create 3D models from
the patient's CT images and Oqton’s Geomagic Freeform® to
complete the design of the patient-specific occipital prosthesis.
The cranial implant was printed using VESTAKEEP® i4 3DF PEEK
by Evonik on 3D Systems’ EXT 220 MED extrusion platform.
The solution has also been successfully deployed at the
Department of Neurosurgery, University Hospital Salzburg, for
patient-specific implants after decompressive craniectomy, which is
regularly performed for aggressive brain swelling. According to
Prof. Christoph Griessenauer, chairman of the department for
neurosurgery in Salzburg, 40 decompressive craniectomies are
performed in Salzburg annually. After the swelling subsides, the
bone is replaced with a patient-specific cranioplasty implant. So
far four cranioplasty surgeries have been performed within the last
month, and multiple more are planned for the future. “We are proud
now to use for the first time a patient-specific cranial implant
printed at our hospital,” said Griessenauer. One of the
departments’ senior attendings, Dr. Pöppe, was spearheading this
effort from the clinical side. “This revolutionary procedure
showcases the power of medical 3D printing in providing
personalized solutions that adhere to regulatory standards. The
success of these procedures marks a significant step forward in the
integration of 3D printing into routine clinical practice,” said
Dr. Pöppe.
"We are proud to be at the forefront of this medical revolution,
leveraging our expertise in 3D printing to bring tangible benefits
to patients," said Stefan Leonhardt, director, medical devices, 3D
Systems. "Our collaboration with hospitals in Europe demonstrates
the potential of 3D printing to transform healthcare, and we are
excited to continue advancing this technology to address a broader
range of medical needs. 3D Systems remains committed to driving
innovation in the field of medical 3D printing, working hand in
hand with healthcare professionals to enhance patient care and
contribute to a brighter, healthier future.”
It is anticipated that the use of 3D-printed cranial implants
will accelerate based on the availability of advanced
technologies. According to a report released by
Acumen Research and Consulting in February 2023, the cranial
implants market size in 2021 was roughly $1.2 billion and is
anticipated to approach $2.1 billion by 2030. Cranial implants can
address a breadth of applications including trauma, defects, and
reconstruction. The continued innovation in materials and
manufacturing methodologies such as 3D printing are expected to
enable new solutions to catalyze growth in this market.
Forward-Looking StatementsCertain statements
made in this release that are not statements of historical or
current facts are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the company to be materially
different from historical results or from any future results or
projections expressed or implied by such forward-looking
statements. In many cases, forward-looking statements can be
identified by terms such as "believes," "belief," "expects," "may,"
"will," "estimates," "intends," "anticipates" or "plans" or the
negative of these terms or other comparable terminology.
Forward-looking statements are based upon management’s beliefs,
assumptions, and current expectations and may include comments as
to the company’s beliefs and expectations as to future events and
trends affecting its business and are necessarily subject to
uncertainties, many of which are outside the control of the
company. The factors described under the headings "Forward-Looking
Statements" and "Risk Factors" in the company’s periodic filings
with the Securities and Exchange Commission, as well as other
factors, could cause actual results to differ materially from those
reflected or predicted in forward-looking statements. Although
management believes that the expectations reflected in the
forward-looking statements are reasonable, forward-looking
statements are not, and should not be relied upon as a guarantee of
future performance or results, nor will they necessarily prove to
be accurate indications of the times at which such performance or
results will be achieved. The forward-looking statements included
are made only as of the date of the statement. 3D Systems
undertakes no obligation to update or review any forward-looking
statements made by management or on its behalf, whether as a result
of future developments, subsequent events or circumstances or
otherwise, except as required by law.
About 3D Systems More than 35 years ago, 3D
Systems brought the innovation of 3D printing to the manufacturing
industry. Today, as the leading additive manufacturing solutions
partner, we bring innovation, performance, and reliability to every
interaction - empowering our customers to create products and
business models never before possible. Thanks to our unique
offering of hardware, software, materials, and services, each
application-specific solution is powered by the expertise of our
application engineers who collaborate with customers to transform
how they deliver their products and services. 3D Systems’ solutions
address a variety of advanced applications in healthcare and
industrial markets such as medical and dental, aerospace &
defense, automotive, and durable goods. More information on the
company is available at www.3dsystems.com.
Investor Contact:
investor.relations@3dsystems.comMedia
Contact: press@3dsystems.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/834f98b4-fb7d-4b7a-80dc-14d0805820d5
3D Systems (NYSE:DDD)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
3D Systems (NYSE:DDD)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024